Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance

Clifford M Takemoto, Michael B Streiff, Kenneth M Shermock, Peggy S. Kraus, Junnan Chen, Jayesh Jani, Thomas Stephen Kickler

Research output: Contribution to journalArticle

Abstract

We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54% of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.

Original languageEnglish (US)
Pages (from-to)450-456
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume139
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Partial Thromboplastin Time
Heparin
Thrombin
Factor VIII
Prothrombin
Therapeutics

Keywords

  • Anti-Xa levels
  • Endogenous thrombin potential
  • Heparin monitoring

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance. / Takemoto, Clifford M; Streiff, Michael B; Shermock, Kenneth M; Kraus, Peggy S.; Chen, Junnan; Jani, Jayesh; Kickler, Thomas Stephen.

In: American Journal of Clinical Pathology, Vol. 139, No. 4, 04.2013, p. 450-456.

Research output: Contribution to journalArticle

@article{b5e5b7bd6c644d91af39132365866430,
title = "Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance",
abstract = "We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54{\%} of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.",
keywords = "Anti-Xa levels, Endogenous thrombin potential, Heparin monitoring",
author = "Takemoto, {Clifford M} and Streiff, {Michael B} and Shermock, {Kenneth M} and Kraus, {Peggy S.} and Junnan Chen and Jayesh Jani and Kickler, {Thomas Stephen}",
year = "2013",
month = "4",
doi = "10.1309/AJCPS6OW6DYNOGNH",
language = "English (US)",
volume = "139",
pages = "450--456",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Activated partial thromboplastin time and anti-xa measurements in heparin monitoring biochemical basis for discordance

AU - Takemoto, Clifford M

AU - Streiff, Michael B

AU - Shermock, Kenneth M

AU - Kraus, Peggy S.

AU - Chen, Junnan

AU - Jani, Jayesh

AU - Kickler, Thomas Stephen

PY - 2013/4

Y1 - 2013/4

N2 - We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54% of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.

AB - We examined the concordance of heparin levels measured by a chromogenic anti-Xa assay and the activated partial thromboplastin time (APTT) during unfractionated heparin therapy (UFH) and the biochemical basis for differences between these measures. We also investigated the endogenous thrombin potential (ETP) as a possible measure of anticoagulation. Paired measures of anti-Xa and APTT were performed on 569 samples from 149 patients on UFH. The anti-Xa values and the APTT were concordant in only 54% of measurements. One hundred twelve samples from 59 patients on UFH were assayed for APTT, anti-Xa, factor II, factor VIII, and ETP. Supratherapeutic APTT values but therapeutic anti-Xa results had decreased factor II activity. Subtherapeutic APTT but therapeutic anti-Xa values had high factor VIII activity. ETP correlated with anticoagulation status and UFH dose. In conclusion, factor II and VIII activity contributes to discordance between APTT and anti-Xa results. ETP measurements may provide an additional assessment of anticoagulation status.

KW - Anti-Xa levels

KW - Endogenous thrombin potential

KW - Heparin monitoring

UR - http://www.scopus.com/inward/record.url?scp=84877249391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877249391&partnerID=8YFLogxK

U2 - 10.1309/AJCPS6OW6DYNOGNH

DO - 10.1309/AJCPS6OW6DYNOGNH

M3 - Article

C2 - 23525615

AN - SCOPUS:84877249391

VL - 139

SP - 450

EP - 456

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -